SGLT2 Inhibitors May Cut Risk for Heart Failure Hospitalization
SGLT2 inhibitors, compared with GLP-1 RAs, linked to lower risk for heart failure hospitalization in patients with T2DM, with or without CVD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.